Director of National Intelligence Tulsi Gabbard is investigating more than 120 biological laboratories abroad that were funded by US taxpayer dollars for decades, as part of an effort to end potentially risky experiments with viruses pursuant to President Trump's executive order on so-called "gain-of-function" research.

Gabbard told The Post Monday in a statement that her team is going "to identify where these labs are, what pathogens they contain and what 'research' is being conducted to end dangerous gain-of-function research that threatens the health and wellbeing of the American people and the world."

"The COVID-19 pandemic revealed the catastrophic global impact research on dangerous pathogens in biolabs can have," the spy chief also said.

"Yet despite these obvious dangers, politicians, so-called health professionals, like Dr. Fauci, and entities within the Biden administration's national security team lied to the American people about the existence of these US-funded and supported biolabs and threatened those who attempted to expose the truth."

Under new guidance from Gabbard, the US Intelligence Community will review research at all US-funded biolabs, which would include facilities engaged in gain-of-function experiments that could increase the transmissibility of viruses, as well as work for defensive purposes against dangerous pathogens.

Office of the Director of National Intelligence officials noted that the foreign labs extend into more than 30 countries, and several had received funding in the past through a Department of Defense program that sought to dispose of weapons of mass destruction after the end of the Cold War.

More than 40 of the biolabs under review are located in Ukraine — and could "be at risk of compromise" due to Russia's war, ODNI officials noted.

The research, which is part of the Defense Department's Cooperative Threat Reduction (CTR) Program, is aimed at studying pathogens to prevent future outbreaks and enhancing biosecurity for the US.

Critics have argued that lax oversight of the research funding, which often flows through US agencies to grantees and subawardees, prevents Americans from knowing whether potentially dangerous experiments are being conducted.

Clinical trials currently being conducted at the biolabs are now "raising significant, ethical, financial and security concerns," ODNI officials said.

The Biden administration denied the existence of US-owned or US-operated "chemical or biological laboratories in Ukraine," dismissing the claims as Chinese and Russian propaganda in a March 9, 2022, statement, the month after Kremlin forces invaded.